Consumer Health IPO Outlook: Oura, Whoop, Strava

May 2026 is one of the most consequential consumer health capital markets moments in years.

The consumer health IPO wave is real and it's happening now. Oura filed its confidential S-1 with the SEC on 21st May 2026, literally yesterday. Strava filed in January 2026 with Goldman Sachs leading and WHOOP's CEO Will Ahmed, after closing a $575M Series G at a $10.1 Billion valuation in March 2026, stated unambiguously: "Our next step is an IPO".

The combined pre-IPO valuation exceeds $23 billion across the three, Oura at ~$11Bn, WHOOP at $10.1Bn, Strava at ~$2.2Bn. 

The Bull Case

All three are profitable or cash flow positive, a fundamental departure from the 2021 SPAC era
Oura has 80%+ first-year subscription renewal rates and a patent moat that has already forced competitors out of the US market via ITC injunctions.

WHOOP's Advanced Labs (blood testing + wearable data, backed by Mayo Clinic and Abbott) is reframing it as a diagnostics platform, which carries a materially higher valuation multiple
Hinge Health (+17%) and Omada (+21%) both popped at debut in 2025, opening the IPO window

The Bear Case / Key Risks

Q1 2026 saw a significant IPO lull, geopolitics, Middle East conflict, tariff uncertainty, and AI valuation resets have kept the VIX above 20.

Public markets are ruthlessly categorising: "infrastructure-grade" health businesses get 8–12x revenue; consumer electronics gets 3–5x and Oura/WHOOP need to win the categorisation argument.

Strava's structural challenge of converting 180M free users into paid subscribers at $79.99/year remains the central IPO diligence question.

Samsung's live ITC challenge to Oura's core ring patents is an unresolved litigation risk.

The strategic implication for European HealthTech is significant: when these S-1s go public, they will be the first detailed look at subscription-plus-hardware health economics at scale and will immediately reprice comparable private assets across diagnostics, remote monitoring, and FemTech on both sides of the Atlantic.

Click here to read the report https://www.healthcare.digital/single-post/oura-whoop-strava-consumer-health-ipo-wave-outlook